Black Diamond Therapeutics, Inc. (BDTX)
2.40
+0.07
(+3.00%)
USD |
NASDAQ |
Apr 02, 16:00
2.40
0.00 (0.00%)
After-Hours: 16:23
Black Diamond Therapeutics Market Cap : 150.40M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bionano Genomics, Inc. | 13.43M |
| IDEAYA Biosciences, Inc. | 2.800B |
| ACADIA Pharmaceuticals, Inc. | 3.794B |
| Alnylam Pharmaceuticals, Inc. | 41.99B |
| Savara, Inc. | 1.162B |
Market Cap Related Metrics
| PE Ratio | 6.902 |
| PS Ratio | 2.142 |
| Price to Book Value | 1.340 |
| Price to Free Cash Flow | 5.064 |
| Price | 2.40 |
| Earnings Yield | 14.49% |
| Operating PE Ratio | 7.548 |
| Normalized PE Ratio | 5.580 |